-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Eiger BioPharmaceuticals, Inc. annual/quarterly Cost of Revenue history and growth rate from Q1 2021 to Q3 2023.
- Eiger BioPharmaceuticals, Inc. Cost of Revenue for the quarter ending September 30, 2023 was $115K, a 90.7% decline year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2023 was $24K, a 98.7% decline from 2022.
- Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2022 was $1.84M, a 147% increase from 2021.
- Eiger BioPharmaceuticals, Inc. annual Cost of Revenue for 2021 was $745K.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)